Dependence of Intracellular and Exosomal microRNAs on Viral Oncogene Expression in HPV-positive Tumor Cells

1. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350. 12044010

2. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L (1988) Correlation of modified human papilloma virus early gene expression with altered growth properties in C4–1 cervical carcinoma cells. Cancer Res 48: 3780–3786. 2837324

3. McLaughlin-Drubin ME, Munger K (2009) Oncogenic activities of human papillomaviruses. Virus Res 143: 195–208. doi: 10.1016/j.virusres.2009.06.008 19540281

4. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129–1136. 2175676

5. Klingelhutz AJ, Foster SA, McDougall JK (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79–82. 8598912

6. McLaughlin-Drubin ME, Munger K (2009) The human papillomavirus E7 oncoprotein. Virology 384: 335–344. doi: 10.1016/j.virol.2008.10.006 19007963

7. Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F (2000) Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci U S A 97: 6693–6697. 10829072

8. Butz K, Ristriani T, Hengstermann A, Denk C, Scheffner M, et al. (2003) siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 22: 5938–5945. 12955072

9. Griffin H, Elston R, Jackson D, Ansell K, Coleman M, et al. (2006) Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting. J Mol Biol 355: 360–378. 16324714

10. Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, et al. (2008) New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 15: 140–153. 18157144

11. Lagrange M, Boulade-Ladame C, Mailly L, Weiss E, Orfanoudakis G, et al. (2007) Intracellular scFvs against the viral E6 oncoprotein provoke apoptosis in human papillomavirus-positive cancer cells. Biochem Biophys Res Commun 361: 487–492. 17658466

12. Goodwin EC, Yang E, Lee CJ, Lee HW, DiMaio D, et al. (2000) Rapid induction of senescence in human cervical carcinoma cells. Proc Natl Acad Sci U S A 97: 10978–10983. 11005870

13. Wells SI, Francis DA, Karpova AY, Dowhanick JJ, Benson JD, et al. (2000) Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways. EMBO J 19: 5762–5771. 11060027

14. Hall AH, Alexander KA (2003) RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol 77: 6066–6069. 12719599

15. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515–524. doi: 10.1016/j.cell.2012.04.005 22541426

16. Cowland JB, Hother C, Gronbaek K (2007) MicroRNAs and cancer. APMIS 115: 1090–1106. 18042145

17. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143–159. doi: 10.1002/emmm.201100209 22351564

18. Olive V, Li Q, He L (2013) mir-17–92: a polycistronic oncomir with pleiotropic functions. Immunol Rev 253: 158–166. doi: 10.1111/imr.12054 23550645

19. Campisi J (2012) Aging, Cellular Senescence, and Cancer. Annu Rev Physiol.

20. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24: 2463–2479. doi: 10.1101/gad.1971610 21078816

21. Kincaid RP, Sullivan CS (2012) Virus-encoded microRNAs: an overview and a look to the future. PLoS Pathog 8: e1003018. doi: 10.1371/journal.ppat.1003018 23308061

22. Wang X, Wang HK, Li Y, Hafner M, Banerjee NS, et al. (2014) microRNAs are biomarkers of oncogenic human papillomavirus infections. Proc Natl Acad Sci U S A 111: 4262–4267. doi: 10.1073/pnas.1401430111 24591631

23. Villegas-Ruiz V, Juarez-Mendez S, Perez-Gonzalez OA, Arreola H, Paniagua-Garcia L, et al. (2014) Heterogeneity of microRNAs expression in cervical cancer cells: over-expression of miR-196a. Int J Clin Exp Pathol 7: 1389–1401. 24817935

24. Lin C, Huang F, Zhang YJ, Tuokan T, Kuerban G (2014) Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer Prev 15: 45–48. 24528073

25. Ma D, Zhang YY, Guo YL, Li ZJ, Geng L (2012) Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer. Chin Med J (Engl) 125: 4270–4276. 23217399

26. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, et al. (2012) Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11: 2876–2884. doi: 10.4161/cc.21278 22801550

27. Lajer CB, Garnaes E, Friis-Hansen L, Norrild B, Therkildsen MH, et al. (2012) The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br J Cancer 106: 1526–1534. doi: 10.1038/bjc.2012.109 22472886

28. Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, et al. (2013) Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 32: 106–116. doi: 10.1038/onc.2012.20 22330141

29. Liu L, Yu X, Guo X, Tian Z, Su M, et al. (2012) miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep 5: 753–760. doi: 10.3892/mmr.2011.696 22160209

30. Li Y, Wang F, Xu J, Ye F, Shen Y, et al. (2011) Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224: 484–495. doi: 10.1002/path.2873 21503900

31. Rao Q, Shen Q, Zhou H, Peng Y, Li J, et al. (2012) Aberrant microRNA expression in human cervical carcinomas. Med Oncol 29: 1242–1248. doi: 10.1007/s12032-011-9830-2 21264530

32. Li JH, Xiao X, Zhang YN, Wang YM, Feng LM, et al. (2011) MicroRNA miR-886–5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol 120: 145–151. doi: 10.1016/j.ygyno.2010.09.009 20947150

33. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MA (2010) MicroRNA expression variability in human cervical tissues. PLoS One 5: e11780. doi: 10.1371/journal.pone.0011780 20668671

34. Wang X, Tang S, Le SY, Lu R, Rader JS, et al. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557. doi: 10.1371/journal.pone.0002557 18596939

35. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535–2542. doi: 10.1158/1078-0432.CCR-07-1231 18451214

36. Witten D, Tibshirani R, Gu SG, Fire A, Lui WO (2010) Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 8: 58. doi: 10.1186/1741-7007-8-58 20459774

37. Park H, Lee MJ, Jeong JY, Choi MC, Jung SG, et al. (2014) Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: Clinical impact of miR-363–3p. Gynecol Oncol 135: 565–572. doi: 10.1016/j.ygyno.2014.09.010 25230213

38. Liang S, Tian T, Liu X, Shi H, Tang C, et al. (2014) Microarray analysis revealed markedly differential miRNA expression profiles in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Future Oncol 10: 2023–2032. doi: 10.2217/fon.14.38 24559408

39. Tang T, Wong HK, Gu W, Yu MY, To KF, et al. (2013) MicroRNA-182 plays an onco-miRNA role in cervical cancer. Gynecol Oncol 129: 199–208. doi: 10.1016/j.ygyno.2012.12.043 23313739

40. Lui WO, Pourmand N, Patterson BK, Fire A (2007) Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031–6043. 17616659

41. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575–2582. 17998940

42. Dreher A, Rossing M, Kaczkowski B, Andersen DK, Larsen TJ, et al. (2011) Differential expression of cellular microRNAs in HPV 11, -16, and-45 transfected cells. Biochem Biophys Res Commun 412: 20–25. doi: 10.1016/j.bbrc.2011.07.011 21782796

43. Gunasekharan V, Laimins LA (2013) Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol 87: 6037–6043. doi: 10.1128/JVI.00153-13 23468503

44. Yablonska S, Hoskins EE, Wells SI, Khan SA (2013) Identification of miRNAs Dysregulated in Human Foreskin Keratinocytes (HFKs) Expressing the Human Papillomavirus (HPV) Type 16 E6 and E7 Oncoproteins. Microrna 2: 2–13. 25070710

45. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, et al. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15: 637–647. doi: 10.1261/rna.1442309 19258450

46. McKenna DJ, McDade SS, Patel D, McCance DJ (2010) MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6. J Virol 84: 10644–10652. doi: 10.1128/JVI.00703-10 20702634

47. Kowal J, Tkach M, Thery C (2014) Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29C: 116–125.

48. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654–659. 17486113

49. Rak J (2013) Extracellular vesicles—biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 4: 21. doi: 10.3389/fphar.2013.00021 23508692

50. Martins VR, Dias MS, Hainaut P (2013) Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 25: 66–75. doi: 10.1097/CCO.0b013e32835b7c81 23165142

51. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, et al. (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107: 6328–6333. doi: 10.1073/pnas.0914843107 20304794

52. Kogure T, Lin WL, Yan IK, Braconi C, Patel T (2011) Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54: 1237–1248. doi: 10.1002/hep.24504 21721029

53. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, et al. (2012) Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756–766. doi: 10.1182/blood-2011-02-338004 22031862

54. Rana S, Malinowska K, Zoller M (2013) Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 15: 281–295. 23479506

55. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32: 2747–2755. doi: 10.1038/onc.2012.295 22797057

56. Meckes DG Jr., Shair KH, Marquitz AR, Kung CP, Edwards RH, et al. (2010) Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 107: 20370–20375. doi: 10.1073/pnas.1014194107 21059916

57. Pegtel DM, van de Garde MD, Middeldorp JM (2011) Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta 1809: 715–721. doi: 10.1016/j.bbagrm.2011.08.002 21855666

58. Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, et al. (2013) Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog 9: e1003484. doi: 10.1371/journal.ppat.1003484 23874201

59. D’Souza-Schorey C, Clancy JW (2012) Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 26: 1287–1299. doi: 10.1101/gad.192351.112 22713869

60. Properzi F, Logozzi M, Fais S (2013) Exosomes: the future of biomarkers in medicine. Biomark Med 7: 769–778. doi: 10.2217/bmm.13.63 24044569

61. Taylor DD, Gercel-Taylor C (2013) The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Front Genet 4: 142. doi: 10.3389/fgene.2013.00142 23908664

62. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825. 8242752

63. Mullokandov G, Baccarini A, Ruzo A, Jayaprakash AD, Tung N, et al. (2012) High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 9: 840–846. doi: 10.1038/nmeth.2078 22751203

64. Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12: 613–626. doi: 10.1038/nrc3318 22898542

65. Hengstermann A, D’Silva M A, Kuballa P, Butz K, Hoppe-Seyler F, et al. (2005) Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J Virol 79: 9296–9300. 15994823

66. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, et al. (2008) Antagomir-17–5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 3: e2236. doi: 10.1371/journal.pone.0002236 18493594

67. Wu S, Huang S, Ding J, Zhao Y, Liang L, et al. (2010) Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 29: 2302–2308. doi: 10.1038/onc.2010.34 20190813

68. DeFilippis RA, Goodwin EC, Wu L, DiMaio D (2003) Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 77: 1551–1563. 12502868

69. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3: Unit 3 22.

70. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13–21. doi: 10.1016/j.ygyno.2008.04.033 18589210

71. Bellingham SA, Coleman BM, Hill AF (2012) Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res.

72. Moldovan L, Batte K, Wang Y, Wisler J, Piper M (2013) Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol 1024: 129–145. doi: 10.1007/978-1-62703-453-1_10 23719947

73. Goodwin EC, DiMaio D (2000) Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci U S A 97: 12513–12518. 11070078

74. Magaldi TG, Almstead LL, Bellone S, Prevatt EG, Santin AD, et al. (2012) Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 422: 114–124. doi: 10.1016/j.virol.2011.10.012 22056390

75. Hwang ES, Riese DJ 2nd, Settleman J, Nilson LA, Honig J, et al. (1993) Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J Virol 67: 3720–3729. 8389903

76. Dowhanick JJ, McBride AA, Howley PM (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69: 7791–7799. 7494290

77. Honegger A, Leitz J, Bulkescher J, Hoppe-Seyler K, Hoppe-Seyler F (2013) Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Int J Cancer.

78. Durst M, Gallahan D, Jay G, Rhim JS (1989) Glucocorticoid-enhanced neoplastic transformation of human keratinocytes by human papillomavirus type 16 and an activated ras oncogene. Virology 173: 767–771. 2556855

79. Kuner R, Vogt M, Sultmann H, Buness A, Dymalla S, et al. (2007) Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses. J Mol Med (Berl) 85: 1253–1262. 17589817

80. Buitrago-Perez A, Garaulet G, Vazquez-Carballo A, Paramio JM, Garcia-Escudero R (2009) Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling. Curr Genomics 10: 26–34. doi: 10.2174/138920209787581235 19721808

81. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, et al. (2009) Modulation of microRNA processing by p53. Nature 460: 529–533. doi: 10.1038/nature08199 19626115

82. Ding H, Wu YL, Wang YX, Zhu FF (2014) Characterization of the microRNA expression profile of cervical squamous cell carcinoma metastases. Asian Pac J Cancer Prev 15: 1675–1679. 24641388

83. Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, et al. (2010) EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70: 8822–8831. doi: 10.1158/0008-5472.CAN-10-0638 20978205

84. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, et al. (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci U S A 105: 13021–13026. doi: 10.1073/pnas.0803304105 18755890

85. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, et al. (2011) An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233–1247. doi: 10.1016/j.cell.2011.10.043 22153071

86. Yang L, Li Y, Cheng M, Huang D, Zheng J, et al. (2012) A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis 33: 338–347. doi: 10.1093/carcin/bgr272 22114071

87. Dhahbi JM, Atamna H, Boffelli D, Magis W, Spindler SR, et al. (2011) Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PLoS One 6: e20509. doi: 10.1371/journal.pone.0020509 21637828

88. Lee DY, Deng Z, Wang CH, Yang BB (2007) MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci U S A 104: 20350–20355. 18077375

89. Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, et al. (2010) Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood 116: e118–127. doi: 10.1182/blood-2010-05-285403 20733160

90. Zhang Y, Gan B, Liu D, Paik JH (2011) FoxO family members in cancer. Cancer Biol Ther 12: 253–259. 21613825

91. Kloet DE, Burgering BM (2011) The PKB/FOXO switch in aging and cancer. Biochim Biophys Acta 1813: 1926–1937. doi: 10.1016/j.bbamcr.2011.04.003 21539865

92. Chhabra R, Dubey R, Saini N (2010) Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24–2 cluster and its implication in human diseases. Mol Cancer 9: 232. doi: 10.1186/1476-4598-9-232 20815877

93. Dellago H, Preschitz-Kammerhofer B, Terlecki-Zaniewicz L, Schreiner C, Fortschegger K, et al. (2013) High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell 12: 446–458. doi: 10.1111/acel.12069 23496142

94. Lee S, Jung JW, Park SB, Roh K, Lee SY, et al. (2011) Histone deacetylase regulates high mobility group A2-targeting microRNAs in human cord blood-derived multipotent stem cell aging. Cell Mol Life Sci 68: 325–336. doi: 10.1007/s00018-010-0457-9 20652617

95. Goto Y, Kojima S, Nishikawa R, Enokida H, Chiyomaru T, et al. (2014) The microRNA-23b/27b/24–1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget.

96. Majid S, Dar AA, Saini S, Arora S, Shahryari V, et al. (2012) miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res 72: 6435–6446. doi: 10.1158/0008-5472.CAN-12-2181 23074286

97. Bonifacio LN, Jarstfer MB (2010) MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts. PLoS One 5.

98. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, et al. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458: 762–765. doi: 10.1038/nature07823 19219026

99. Jiang S, Zhang LF, Zhang HW, Hu S, Lu MH, et al. (2012) A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells. EMBO J 31: 1985–1998. doi: 10.1038/emboj.2012.45 22354042

100. White EA, Walther J, Javanbakht H, Howley PM (2014) Genus Beta Human Papillomavirus E6 Proteins Vary in Their Effects on the Transactivation of p53 Target Genes. J Virol 88: 8201–8212. doi: 10.1128/JVI.01197-14 24850740

101. Funk JO, Waga S, Harry JB, Espling E, Stillman B, et al. (1997) Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev 11: 2090–2100. 9284048

102. Jones DL, Alani RM, Munger K (1997) The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 11: 2101–2111. 9284049

103. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834–838. 15944708

104. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189–198. 16530703

105. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, et al. (2013) Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun 4: 2980. doi: 10.1038/ncomms3980 24356509

106. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19–36. doi: 10.1677/ERC-09-0184 19779035

107. Nuovo GJ, Garofalo M, Valeri N, Roulstone V, Volinia S, et al. (2012) Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Mod Pathol 25: 1333–1344. doi: 10.1038/modpathol.2012.95 22699519

108. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, et al. (2012) Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A 109: 3024–3029. doi: 10.1073/pnas.1200010109 22315424

109. Hong L, Lai M, Chen M, Xie C, Liao R, et al. (2010) The miR-17–92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res 70: 8547–8557. doi: 10.1158/0008-5472.CAN-10-1938 20851997

110. Li M, Guan X, Sun Y, Shu X, Li C (2014) miR-92a family and their target genes in tumorigenesis and metastasis. Exp Cell Res.

111. Di Leva G, Garofalo M, Croce CM (2014) MicroRNAs in cancer. Annu Rev Pathol 9: 287–314. doi: 10.1146/annurev-pathol-012513-104715 24079833

112. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200: 373–383. doi: 10.1083/jcb.201211138 23420871

113. Bobrie A, Colombo M, Raposo G, Thery C (2011) Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12: 1659–1668. doi: 10.1111/j.1600-0854.2011.01225.x 21645191

114. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39: 7223–7233. doi: 10.1093/nar/gkr254 21609964

115. Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, et al. (2013) Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A 110: 4255–4260. doi: 10.1073/pnas.1214046110 23440203

116. Nouraee N, Calin GA (2013) MicroRNAs as Cancer Biomarkers. Microrna 2: 102–117. 25070780

117. Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20: 460–469. doi: 10.1016/j.molmed.2014.06.005 25027972

118. Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679. doi: 10.1371/journal.pone.0030679 22427800

119. Nana-Sinkam SP, Croce CM (2013) Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 93: 98–104. doi: 10.1038/clpt.2012.192 23212103

120. Parsons BD, Schindler A, Evans DH, Foley E (2009) A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS One 4: e8471. doi: 10.1371/journal.pone.0008471 20041186

121. Jackson AL, Linsley PS (2010) Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 9: 57–67. doi: 10.1038/nrd3010 20043028

122. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745–2752. 3670292

123. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839–843. 15944709

124. Fox MH (1980) A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1: 71–77. 7023881

125. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92: 9363–9367. 7568133

126. Butz K, Geisen C, Ullmann A, Zentgraf H, Hoppe-Seyler F (1998) Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress. Oncogene 17: 781–787. 9715280

127. Crnkovic-Mertens I, Semzow J, Hoppe-Seyler F, Butz K (2006) Isoform-specific silencing of the Livin gene by RNA interference defines Livin beta as key mediator of apoptosis inhibition in HeLa cells. J Mol Med (Berl) 84: 232–240. 16437214

128. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408. 11846609

129. Friedlander MR, Mackowiak SD, Li N, Chen W, Rajewsky N (2012) miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res 40: 37–52. doi: 10.1093/nar/gkr688 21911355

130. Weischenfeldt J, Simon R, Feuerbach L, Schlangen K, Weichenhan D, et al. (2013) Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23: 159–170. doi: 10.1016/j.ccr.2013.01.002 23410972

131. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109–111. 14681370

132. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140–144. 16381832

133. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154–158. 17991681

134. Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152–157. doi: 10.1093/nar/gkq1027 21037258